HEALTH CARE RESOURCE UTILIZATION AND COSTS OF METASTATIC NON-SMALL CELL LUNG CANCER IN SELECT EUROPEAN COUNTRIES

Kurosky S.; Lorenzo M.; Carter Cuyun G.; Parikh R. C.; Winfree K.; Kaye J. A.

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >HEALTH CARE RESOURCE UTILIZATION AND COSTS OF METASTATIC NON-SMALL CELL LUNG CANCER IN SELECT EUROPEAN COUNTRIES

【24h】

HEALTH CARE RESOURCE UTILIZATION AND COSTS OF METASTATIC NON-SMALL CELL LUNG CANCER IN SELECT EUROPEAN COUNTRIES

机译：选择欧洲国家的医疗保健资源利用率和转移性非小细胞肺癌的成本

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2017年第5期|共1页
作者
Kurosky S.; Lorenzo M.; Carter Cuyun G.; Parikh R. C.; Winfree K.; Kaye J. A.;
展开▼
作者单位

RTI Hlth Solut Res Triangle Pk NC USA;

Eli Lilly &

Co Ltd Windlesham Surrey England;

Eli Lilly &

Co Indianapolis IN 46285 USA;

RTI Hlth Solut Res Triangle Pk NC USA;

Eli Lilly &

Co Indianapolis IN 46285 USA;

RTI Hlth Solut Waltham MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. HEALTH CARE RESOURCE UTILIZATION AND COSTS OF METASTATIC NON-SMALL CELL LUNG CANCER IN SELECT EUROPEAN COUNTRIES [J] . Kurosky S., Lorenzo M., Carter Cuyun G., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：选择欧洲国家的医疗保健资源利用率和转移性非小细胞肺癌的成本
2. THE ASSOCIATION BETWEEN INITIATION OF GUIDELINE RECOMMENDED FIRST-LINE SYSTEMIC THERAPY AND HEALTHCARE COSTS AND UTILIZATION IN A METASTATIC NON-SMALL CELL LUNG CANCER (MNSCLC) POPULATION [J] . Casebeer A. W., Hopson S., Antol Drzayich D., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：指南推荐的一线系统治疗和医疗费用与转移性非小细胞肺癌（MNSCLC）人群的使用之间的关联
3. The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors [J] . Janakiraman Subramanian, Ancilla W. Fernes, Francois Laliberte, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：用第一和第二代表皮生长因子受体酪氨酸激酶抑制剂治疗的转移性非小细胞肺癌患者的转移性非小细胞肺癌患者的发生率，医疗资源使用和不良事件的成本
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. Survival, Healthcare Utilization, and Costs Associated with Chronic Obstructive Pulmonary Disease Among Seer-Medicare Beneficiaries with Non-Small Cell Lung Cancer [D] . Shah, Shweta. 2017

机译：非小细胞肺癌先知医疗受益者的慢性阻塞性肺疾病的生存率，医疗保健利用率和成本
6. Comparison of demographics treatment patterns health care utilization and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers [O] . Sudeep J Karve, Gregory L Price, Keith L Davis, 2014

机译：老年小细胞肺癌和转移性非小细胞肺癌老年患者的人口统计学治疗方式医疗保健利用和费用比较
7. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers [O] . Sudeep J Karve, Gregory L Price, Keith L Davis, 2014

机译：老年小细胞肺癌和转移性非小细胞肺癌老年患者的人口统计学，治疗方式，医疗保健利用和费用比较

HEALTH CARE RESOURCE UTILIZATION AND COSTS OF METASTATIC NON-SMALL CELL LUNG CANCER IN SELECT EUROPEAN COUNTRIES

著录项

相似文献

相关主题

期刊订阅